Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study

INTRODUCTION: Concerns over potential drug‐drug interactions (DDI) between feminizing hormone therapy (FHT) and pre‐exposure prophylaxis (PrEP) have hampered uptake and adherence of PrEP among transgender women (TGW). To determine DDI between FHT and PrEP, we measured the pharmacokinetic (PK) parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiransuthikul, Akarin, Janamnuaysook, Rena, Himmad, Kanittha, Kerr, Stephen J, Thammajaruk, Narukjaporn, Pankam, Tippawan, Phanjaroen, Kannapat, Mills, Stephen, Vannakit, Ravipa, Phanuphak, Praphan, Phanuphak, Nittaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625338/
https://www.ncbi.nlm.nih.gov/pubmed/31298497
http://dx.doi.org/10.1002/jia2.25338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625338/
https://www.ncbi.nlm.nih.gov/pubmed/31298497
http://dx.doi.org/10.1002/jia2.25338

Ejemplares similares